Purpose: Schisandra is a well-known traditional Chinese medicine in East Asia. As a traditional Chinese medicine derivative with Schisandra chinensis as raw material, bicyclol is well known for its signi cant anti-in ammatory effect. Chronic in ammation plays an signi cant part in obesity-induced cardiomyopathy. Our purpose was to explore the effect and mechanism of bicyclol on obesity-induced cardiomyopathy.Methods: Mice fed with a high-fat diet (HFD) and cardiomyocytes stimulated by palmitic acid (PA) were used as models of obesity-related cardiomyopathy in vivo and in vitro, respectively. The therapeutic effect of bicyclol on pathological changes such as myocardial hypertrophy and brosis was evaluated by staining cardiac tissue sections. PCR was used to detect in ammatory factors in H9c2 cells and animal heart tissue after bicyclol treatment. Then, we used western blotting to detect the expression levels of myocardial hypertrophy related protein, myocardial brosis related protein, NF-κB and MAPK pathways.Results: Our results indicated that bicyclol treatment signi cantly alleviates HFD-induced myocardial in ammation, brosis and hypertrophy by inhibiting the MAPK and NF-κB pathways. Similar to animal level results, bicyclol could signi cantly inhibit PA-induced in ammation and prevent NF-κB and MAPK pathways to be activated. Conclusion: Our results showed that bicyclol is expected to become a potential drug to treat obesityinduced cardiomyopathy.
Purpose: Schisandra is a well-known traditional Chinese medicine in East Asia. As a traditional Chinese medicine derivative with Schisandra chinensis as raw material, bicyclol is well known for its significant anti-inflammatory effect. Chronic inflammation plays an significant part in obesity-induced cardiomyopathy. Our purpose was to explore the effect and mechanism of bicyclol on obesity-induced cardiomyopathy. Methods: Mice fed with a high-fat diet (HFD) and cardiomyocytes stimulated by palmitic acid (PA) were used as models of obesity-related cardiomyopathy in vivo and in vitro, respectively. The therapeutic effect of bicyclol on pathological changes such as myocardial hypertrophy and fibrosis was evaluated by staining cardiac tissue sections. PCR was used to detect inflammatory factors in H9c2 cells and animal heart tissue after bicyclol treatment. Then, we used western blotting to detect the expression levels of myocardial hypertrophy related protein, myocardial fibrosis related protein, NF-κB and MAPK pathways.Results: Our results indicated that bicyclol treatment significantly alleviates HFD-induced myocardial inflammation, fibrosis and hypertrophy by inhibiting the MAPK and NF-κB pathways. Similar to animal level results, bicyclol could significantly inhibit PA-induced inflammation and prevent NF-κB and MAPK pathways to be activated.Conclusion: Our results showed that bicyclol is expected to become a potential drug to treat obesity-induced cardiomyopathy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.